North America
The North American Chronic obstructive pulmonary disease copd market is a significant contributor globally, driven by the high prevalence of COPD, increasing awareness regarding respiratory diseases, and advanced healthcare infrastructure. The market benefits from the availability of innovative therapies and devices for COPD management. The United States dominates this...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian